Table 2. Outcomes for Patients Treated With TTM at 33 °C or 36 °C.
| Outcome | No. (%) | |
|---|---|---|
| TTM at 33 °C (n = 728) | TTM at 36 °C (n = 591) | |
| Survived hospitalization | 178 (24.5) | 173 (29.3) |
| ICU length of stay, median (IQR), d | 9.5 (6-18) | 8 (5-15) |
| Hospital length of stay, median (IQR), d | 17.5 (11-26) | 16 (10-25) |
| Modified Rankin Scale | ||
| 0 | 7 (3.9) | 2 (1.2) |
| 1 | 11 (6.2) | 10 (5.8) |
| 2 | 21 (11.8) | 23 (13.3) |
| 3 | 22 (12.4) | 24 (13.9) |
| 4 | 68 (38.2) | 67 (38.7) |
| 5 | 49 (27.5) | 47 (27.2) |
| Cerebral performance category | ||
| 1 | 18 (10.1) | 11 (6.4) |
| 2 | 25 (14.0) | 26 (15.0) |
| 3 | 115 (64.6) | 123 (71.1) |
| 4 | 20 (11.2) | 13 (7.5) |
| Died in hospital | 550 (75.5) | 418 (70.7) |
| ICU length of stay, median (IQR), d | 3 (1-4) | 2 (1-5) |
| Mode of death | ||
| Rearrest, intractable shock, or multiple organ failure | 121 (22.0) | 121 (28.9) |
| WLST, nonneurologic reasons | 50 (9.1) | 75 (17.9) |
| WLST, neurologic prognosis | 327 (59.5) | 181 (43.3) |
| Brain death | 52 (9.5) | 41 (9.8) |
Abbreviations: ICU, intensive care unit; IQR, interquartile range; TTM, targeted temperature management; WLST, withdrawal of life-sustaining therapies.